Business Wire

STV to Deploy Post-Quantum’s Secure Communications Platform, Forms Strategic Cooperation to Deliver Next-Generation Security

Share

STV Group a.s. (“STV”), one of the world’s fastest-growing defence innovators, has signed a multi-year licence agreement to use Post-Quantum’s groundbreaking quantum-safe communications platform and signed a Strategic Cooperation Agreement to accelerate deployment across Europe, NATO, and global defence markets. With quantum computing threatening to render traditional encryption obsolete, the move positions STV at the forefront of the cybersecurity revolution - arming governments, defence forces, and enterprises with next-generation resilience against “Harvest Now, Decrypt Later” attacks.

By fusing Post-Quantum’s NATO-tested modular platform with its own world-class defence solutions, STV is setting a new global benchmark for secure communications and digital trust. Together, the two companies are delivering the most advanced, future-proof systems to protect sensitive data and mission-critical operations - ensuring that even in the quantum era, allied communications remain impenetrable.

The partnership represents a decisive leap forward, combining STV’s defence innovation track record with Post-Quantum’s pioneering expertise to deliver communications and data protection systems that go beyond current industry standards.

JUDr. Pavel Kudrhalt, CEO of STV, said: “This isn’t just about acquiring technology - it’s about building an uncompromising, end-to-end secure ecosystem for the future. Our customers demand full supply chain assurance, from manufacturing and tamper-proof transport to deployment and monitoring. With the rising threat of ‘Harvest Now, Decrypt Later’ attacks, quantum-safe defences are no longer optional. Post-Quantum’s platform doesn’t just lead the field - it allows STV to be the first-mover to redefine the very standards of digital trust in defence solutions. By embedding their technology into our portfolio, we are giving NATO allies, EU partners, and national clients the strongest possible protection for the quantum era - whether that’s safeguarding command and control chains, operating mission-critical drones, or deploying munitions in battlefield communications.”

Rikky Hasan, CEO of Post-Quantum, added: “STV’s vision and leadership in defence innovation make them the ideal partner. Together we are unleashing a new wave of secure, quantum-safe solutions that protect the world’s most sensitive data against today’s adversaries and tomorrow’s quantum threats. Our modular approach to Identity, Transmission and Encryption - already proven in NATO environments - offers the fastest and most agile way to integrate into STV’s global portfolio. This is a proud moment for both companies, and a milestone for global cybersecurity.”

This acquisition and alliance signal the dawn of a new era: one where quantum-resilient platforms are no longer optional, but essential. United by a shared mission to safeguard the future, STV and Post-Quantum are leading the charge toward a world where critical communications remain impenetrable - even in the face of quantum computing’s disruptive power.

About STV

STV Group a.s. is one of Europe’s fastest-growing defence innovators, delivering advanced security and defence solutions to governments, NATO allies, and commercial partners worldwide. Headquartered in the Czech Republic, the company combines cutting-edge engineering with a bold vision for the future of security.

Building on a century of industrial tradition, STV Group has become the Czech Republic’s leading producer of munitions, loitering systems, armoured vehicle platforms and integrated lifecycle services. The group is also a European leader in ecological disposal and demilitarisation of surplus ammunition, underscoring its commitment to safety and sustainability. With NATO-tested technologies and global partnerships, STV Group is trusted to deliver the resilient, future-proof capabilities that keep nations secure in an era of emerging threats.

About Post-Quantum

Post-Quantum is leading the charge into the quantum era by upgrading the world’s encryption. Its quantum-safe platform protects organisations across their entire digital footprint with modular software for Identity, Transmission, and Encryption—designed to be interoperable, crypto-agile and seamlessly backward compatible.

Already trusted by NATO, critical national infrastructure providers, and major financial institutions, Post-Quantum has a proven track record in safeguarding mission-critical data. The company is the inventor of NTS-KEM (now known as Classic McEliece in the NIST competition) and the author of the IETF’s Hybrid Post-Quantum VPN standard, which is now the global benchmark for secure connectivity. With its pioneering technologies, Post-Quantum is ensuring the world stays one step ahead of the quantum threats.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251104052022/en/

Contacts

For further information, please contact:
Fire on the Hill
Nick Ward. +44 (0)7821 474 272
nward@fireoth.com
postquantum@fireoth.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Esri Supports IUCN Global Initiative for Nature-Based Education4.11.2025 15:00:00 EET | Press release

At the 2025 IUCN World Conservation Congress, Esri, the global leader in geographic information system (GIS) technology, announced a joint initiative with the International Union for Conservation of Nature (IUCN) and its Commission on Education and Communication to expand access to data, maps, and GIS technology in support of Nature-based Education (NbE) worldwide. Esri is making a $10 million in-kind donation to enable the development of a new NbE geoportal that will allow students, teachers, and IUCN conservationists around the world to understand and explore our planet through maps and the science of geography, collaborate on critical conservation solutions, and develop critical technical skills for future careers in conservation. This new initiative, now in the pilot phase of consultation and design, will support IUCN’s NbE aspirations to promote environmental learning and action as adopted by the Members during the IUCN World Conservation Congress in Abu Dhabi this October. This c

Visa and Transcard Collaborate to Deliver Advanced Embedded Working Capital Solutions in Freight & Logistics4.11.2025 15:00:00 EET | Press release

Visa and Transcard today announced the launch of a next-generation embedded finance platform, designed to power payments and working capital solutions in the freight and logistics industry. As a part of their joint effort, Visa and Transcard are also collaborating on agentic initiatives for the B2B segment. This alliance puts embedded credit and working capital solutions in the hands of freight forwarders and airline carriers on WebCargo by Freightos (Nasdaq: CRGO), a leading digital booking and payments platform in the freight industry. By combining Visa’s global expertise in commercial solutions with Transcard’s leading-edge payment orchestration technology, WebCargo users can now gain access to flexible credit terms, seamless onboarding and automated reconciliation for air cargo transactions. The solution, built on Visa’s virtual card infrastructure, unlocks the cash flow bottlenecks between freight forwarders and airlines, and elevates the digital freight booking and payment experi

Agendia to Present Five Posters Demonstrating the Expanding Clinical Utility of MammaPrint + BluePrint at the 2025 San Antonio Breast Cancer Symposium4.11.2025 14:00:00 EET | Press release

Agendia®, Inc., a leader in precision oncology for breast cancer, today announced it will present new results from the ongoing real-world FLEX Study (NCT03053193) at the 2025 San Antonio Breast Cancer Symposium (SABCS), taking place December 9-12 in San Antonio, Texas. The company will present five posters, led by Agendia investigators and independent academic collaborators, that collectively highlight the broad clinical impact of MammaPrint® + BluePrint® genomic profiling in optimizing treatment decisions and improving outcomes for patients with hormone receptor positive, HER2-negative (HR+/HER2–) early breast cancer (EBC). “We look forward to sharing these new findings from the FLEX Study, which spans more than 20,000 participants across 100 global sites, making it the largest and most diverse real-world evidence cohort for early-stage breast cancer,” said William Audeh, M.D., Chief Medical Officer at Agendia. “These results underscore our commitment to generating robust clinical evi

Nature Communications Study Supports HER2DX as a Genomic Tool for Tailored Therapy in Older Individuals With HER2+ Breast Cancer4.11.2025 14:00:00 EET | Press release

REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company seeking to revolutionize precision oncology through biomarker innovation, today announced the publication of the study “HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy” in Nature Communications. This landmark study evaluated the HER2DX genomic assay in 154 individuals aged 70–80 years enrolled in the RESPECT trial (NCT01104935), a randomized phase III study comparing adjuvant trastuzumab with or without chemotherapy. The analysis, known as Trans-RESPECT, is the first to evaluate HER2DX in an older adult population, a demographic historically underrepresented in clinical trials. Bringing Precision Oncology to Older Individuals with HER2+ Disease Despite the growing number of older adults diagnosed with HER2-positive early breast cancer, optimal treatment strategies remain unclear. Many face increased risks of chemotherapy-related toxicit

Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months4.11.2025 13:30:00 EET | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2025 and provided an update on recent progress across its business. “With the completion of COMP006 enrollment and our recent positive discussions with the FDA, we are excited about pulling forward our expected launch timing for COMP360 in TRD by 9-12 months,” said Kabir Nath, Chief Executive Officer at Compass Pathways. “We are accelerating commercial launch plans to match this new expected timeline with the goal of advancing our mission of transforming the mental health landscape and how patients living with depression are treated.” Business Highlights COMP360 psilocybin treatment in TRD (Treatment Resistant Depression) Second Phase 3 trial, COMP006, has completed enrollment (n=585) In June 2025, we announced achievement of the 6-week primary endpoint in the first of two phase 3

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye